The world-wide Anticoagulants market is expected to garner USD 39 billion by 2026 and the market is expected to register CAGR growth over 7.9% during the next eight years.
Growing need for controlling the diseases such as kidney diseases and cardiovascular diseases is expected to propel the market growth over forecast period. In addition to this, rise in obesity patient and hence related disorders is another factor which is ultimately boosting the adoption of Anticoagulants in the healthcare areas and hence driving the market growth.
The worldwide anticoagulants market is anticipated to show significant growth during the forecast period, due to the increasing prevalence of cardiovascular disorders, venous thromboembolism (VTE), and others. Also, increasing adoption of novel oral anticoagulants (NOACs), and rising awareness of NOACs and it’s benefits in the emerging regions are boosting the market growth. The increasing obesity issues and rising population of elderly people, and rise in demand of novel therapeutics are some of the other factors driving the market growth. On the other hand, higher price of NOACs and lack of awareness about the anticoagulants to hamper the market growth.
The anticoagulant are drugs which functions as a blood thinners. The anticoagulants are used for preventing or reducing the coagulation of blood also used to prolong the blood clotting time. These drugs are majorly used for high risk of blood clots in various medical conditions. The importance of anticoagulants in preventing the clot formation in the human body is foreseen to be prime factor driving the market growth. Also, anticoagulants are used in the prevention of enlargement of the existing clots in the vein or arteries so that the health hazards are reduced to significant level.
Such properties of Anticoagulants are making them one of the irreplaceable part in the operational areas associated with the heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction. In addition, anticoagulants plays an outstanding role while performing the surgery.
Market By Route of Administration
Market By Drug Class
Market By Distribution Channel
Market By Indication
Market By Geography
In terms of consumption of anticoagulants, the North America was the dominant region in the year 2018 and the similar trend is expected to continue over forecast period due to rapid increase in the surgeries such as hip and knee surgeries in this region. Europe region is following the North America in terms of demand for anticoagulants. Increase in geriatric population is expected to be one of the key factor boosting the demand for anticoagulant in this region.
On the other hand, APAC region is expected to register significant CAGR growth rate over forecast period. The increasing health issues due to changing lifestyle as well as increasing surgical operations in this region are some of the prime factors accelerating the demand for anticoagulants in this region. Also, increasing network of healthcare facilities is expected to be another factor creating a demand for anticoagulants.
The key players operating in the global anticoagulants market are Bristol-Myers Squibb Company, Pfizer, Inc., Bayer Healthcare, Sanofi, Boehringer Ingelheim International GmbH, Johnson & Johnson Services, Inc., and Daiichi Sankyo Company Limited.
The global ambulatory surgical and emergency centers market is expected to grow at a CAGR of 6.2% over the forecast period 2019 to 2026 and market size is poised to reach US$ 203.1 Bn by 2026. Ambulatory surgery and emergency centers are medical care facilities that provide same-day surgery care which also includes consultation and diagnosis. It is a more convenient alternative to hospital based outpatient pro
The global ambulatory health care services market size is expected to surpass US$ 4.4 Tn by 2026 and will grow at a noteworthy CAGR of 5.9% over the forecast period 2019 to 2026. Ambulatory service centers (ASC) also referred as outpatient care centers. These are medical care facilities that provide outpatient services such as consultation, diagnosis, treatment, and intervention services. It is a more convenie
The global ambulatory EHR market size is expected to reach US$ 6.8 billion by 2026 and will grow at a CAGR of around 6.0% over the forecast period 2019 to 2026. The digital version of the patient’s record is known as the electronic health records. It includes a wide range of patient’s information such as medical history, ongoing medication, allergies, personal statistics, the status of immunization, demographics, and laborator
The global cancer biomarkers market size is expected to reach around US$ 29.8 Bn by 2026 and will grow at noteworthy CAGR of around 11.9% over the forecast period 2019 to 2026. Cancer biomarker is a substance that helps to indicate the presence of cancer in the body. This substance may be a molecule secreted by a tumor or specific response of the body to a tumor. Genetic, proteomic
The global 4D printing in healthcare market size is expected to reach around US$ 34.1 Mn by 2026 growing at a CAGR of around 29.6% over the forecast period 2019 to 2026. 4D printing is the latest technology in healthcare that is going to revolutionize the artificial organs and prosthetics industry. 4D printing is a product of collaboration work between MIT’s Lab and Stratasys. 4D printing is evolved 3D p
The global healthcare consulting services market size is expected to reach around US$ 22.8 Bn by 2026 and growing at a CAGR of around 9.8% over the forecast period 2019 to 2026. Healthcare consultancy service providers advice life science companies, government bodies, hospitals, insurance companies, and research institutes about business strategies. Digital consulting, financial consulting, operations consulta